4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000060
General Counsel sold 733 shares at $69.69 ($51,083)
From the SEC's structured data for this filing
Trades in this filing
Quinlan Paul T · General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Sale : show line 1 in the form | −733 | $69.69 | $51,083 | 31,034 | D |
| Open-market sales · 733 sh · avg $69.69 · $51,083 | ||||||
Loading xslF345X06/form4.xml…